Loading
NAV
₹46.1631
+0.24%on 6 Oct 2026
−13.61%over 1 year
Against the average of Sectoral & Thematic funds (direct plans, growth option). A year and longer are yearly averages.
| Period | Fund | Category average | Rank |
|---|---|---|---|
| 1 month | −7.04% | −3.49% | 245 of 248 |
| 3 months | +1.35% | −1.76% | 56 of 246 |
| 6 months | +0.61% | +11.68% | 231 of 246 |
| 1 year | −13.60% | +3.85% | 223 of 224 |
| 3 years | +3.54% | +13.97% | 135 of 138 |
| 5 years | +2.29% | +12.20% | 99 of 99 |
| 10 years | +17.14% | +14.07% | 8 of 68 |
₹10,000 invested on the same day every month, valued at the latest NAV.
| For | Invested | Worth now | XIRR |
|---|---|---|---|
| 1 year | ₹1.20 lakh | ₹1.11 lakh | −13.58% |
| 3 years | ₹3.60 lakh | ₹3.24 lakh | −6.67% |
| 5 years | ₹6.00 lakh | ₹6.17 lakh | +1.11% |
XIRR is the yearly return on money that went in at different times. Try your own amount and start date in the Mutual Fund Returns calculator.
The highest 3-year returns in the category, direct plans. At least 80% in one sector (banking, pharma) or theme (consumption, infrastructure).
| Fund | 1Y | 3Y | 5Y |
|---|---|---|---|
| Nippon India Taiwan Equity FundNippon India Mutual Fund | +128.21% | +63.43% | n/a |
| HDFC Defence FundHDFC Mutual Fund | +21.28% | +36.40% | n/a |
| HDFC Pharma and Healthcare FundHDFC Mutual Fund | +25.98% | +30.12% | n/a |
| Nippon India Japan Equity FundNippon India Mutual Fund | +29.37% | +24.84% | +12.44% |
| Franklin Asian Equity FundFranklin Templeton Mutual Fund | +31.28% | +24.54% | +9.32% |
| Aditya Birla Sun Life International Equity FundAditya Birla Sun Life Mutual Fund | +18.75% | +23.64% | +13.25% |
A direct plan is bought from the fund house itself and costs less each year than the regular plan, which pays a distributor's commission. Growth reinvests gains; IDCW pays some out.
NAVs from AMFI; NAV history from mfapi.in, which republishes AMFI's. Returns are past returns and do not promise future ones. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. For information only, not a recommendation to invest.